Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Journal of Neuro-Oncology
|
October 19, 2010
Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma
Jaime Gállego Pérez-Larraya, José Alberto Palma, María Carmona-Iragui, et al.
Haematologica
|
November 16, 2016
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
Francisco-Javier Peñalver, Juan-Manuel Sancho, Adolfo de la Fuente, et al.
Journal of Immunological Methods
|
January 3, 2017
A simple flow-cytometry method to evaluate peripheral blood contamination of bone marrow aspirates
José Antonio Delgado, Francisco Guillén-Grima, Cristina Moreno, et al.
Pharmacology Research & Perspectives
|
September 18, 2020
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6
Jan de Jong, Anna Mitselos, Wojciech Jurczak, et al.
Genes, Chromosomes & Cancer
|
August 31, 2002
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome
María D Odero, José L Vizmanos, José P Román, et al.
Immunologic Research
|
December 15, 2015
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity
Ricardo García-Muñoz, Ascensión López-Díaz-de-Cerio, Jesus Feliu, et al.
European Journal of Haematology
|
May 28, 2016
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
Nicolás Martínez-Calle, Ana Alfonso, José Rifón, et al.
Leukemia & Lymphoma
|
January 20, 2009
Prolonged idiotypic vaccination against follicular lymphoma
Susana Inoges, Ascension Lopez-Diaz de Cerio, Natalia Zabalegui, et al.
Cancer
|
February 24, 2009
Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma
Jose A Garcia-Marco, Carlos Panizo, Eva Sanchez Garcia, et al.
Immunotherapy
|
March 23, 2018
Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia
Ricardo García-Muñoz, Lorea Aguinaga, Jesus Feliu, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Journal of Neuro-Oncology
|
October 19, 2010
Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma
Jaime Gállego Pérez-Larraya, José Alberto Palma, María Carmona-Iragui, et al.
Haematologica
|
November 16, 2016
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
Francisco-Javier Peñalver, Juan-Manuel Sancho, Adolfo de la Fuente, et al.
Journal of Immunological Methods
|
January 3, 2017
A simple flow-cytometry method to evaluate peripheral blood contamination of bone marrow aspirates
José Antonio Delgado, Francisco Guillén-Grima, Cristina Moreno, et al.
Pharmacology Research & Perspectives
|
September 18, 2020
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6
Jan de Jong, Anna Mitselos, Wojciech Jurczak, et al.
Genes, Chromosomes & Cancer
|
August 31, 2002
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome
María D Odero, José L Vizmanos, José P Román, et al.
Immunologic Research
|
December 15, 2015
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity
Ricardo García-Muñoz, Ascensión López-Díaz-de-Cerio, Jesus Feliu, et al.
European Journal of Haematology
|
May 28, 2016
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
Nicolás Martínez-Calle, Ana Alfonso, José Rifón, et al.
Leukemia & Lymphoma
|
January 20, 2009
Prolonged idiotypic vaccination against follicular lymphoma
Susana Inoges, Ascension Lopez-Diaz de Cerio, Natalia Zabalegui, et al.
Cancer
|
February 24, 2009
Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma
Jose A Garcia-Marco, Carlos Panizo, Eva Sanchez Garcia, et al.
Immunotherapy
|
March 23, 2018
Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia
Ricardo García-Muñoz, Lorea Aguinaga, Jesus Feliu, et al.
Page
of 6